SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-150326
Filing Date
2021-05-05
Accepted
2021-05-04 18:14:05
Documents
17
Period of Report
2021-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d266152d8k.htm   iXBRL 8-K 34158
2 EX-10.1 d266152dex101.htm EX-10.1 503895
3 EX-10.2 d266152dex102.htm EX-10.2 27778
4 EX-10.3 d266152dex103.htm EX-10.3 37592
5 EX-99.1 d266152dex991.htm EX-99.1 28807
9 GRAPHIC g266152snap.jpg GRAPHIC 10096
  Complete submission text file 0001193125-21-150326.txt   895645

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atnx-20210504.xsd EX-101.SCH 3065
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20210504_lab.xml EX-101.LAB 18137
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20210504_pre.xml EX-101.PRE 11404
10 EXTRACTED XBRL INSTANCE DOCUMENT d266152d8k_htm.xml XML 3344
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 21890295
SIC: 2834 Pharmaceutical Preparations